Sergio Camillo Todde - Researcher

Department and institution: School of Medicine and Surgery, University of Milano Bicocca
tel. +39 02 6448 8287
Curriculum Vitae
institutional profile page: UNIMIB
see also: PubMed, BOA
Other related links:

Keywords: cyclotron, PET, radiopharmaceuticals

Main topics of the group

    development, preclinical and clinical evaluation of new radiopharmaceuticals for Positron Emission Tomography

Current research projects

    Project "Multimodal imaging approach for identification of new potential biomarker for treatment response in glioma models", funded by AIRC

Selected pubblications

    1. Todde S, Moresco RM, Simonelli P, Baraldi PG, Cacciari B, Spalluto G, Varani K, Monopoli A, Matarrese M, Carpinelli A, Magni F, Galli Kienle M, Fazio F. Design, radiosynthesis and biodistribution of a new potent and selective ligand for the in vivo imaging of adenosine A2A receptor system using positron emitting tomography. J. Med. Chem. 2000; 43: 4359-4362
    2. Calandrino R, Del Vecchio A, Savi A, Todde S, Griffoni V, Brambilla S, Parisi R, Simone G, Fazio F. Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time. Health Phys, 2006; 90 (6): 588-596.
    3. Matarrese M, Bedeschi P, Scardaoni R, Sudati F, Savi A, Pepe A, Masiello V, Todde S, Gianolli L, Messa C, Fazio F. Automated production of copper radioisotopes and preparation of high specific activity [64Cu]Cu-ATSM for PET studies. Appl. Radiat. Isot. 2010; 68: 5-13
    4.Todde S, Windhorst AD, Behe M, Bormans G, Decristoforo C, Faivre-Chauvet A, Ferrari V, Gee AD, Gulyas B, Halldin C, Kolenc Peitl P, Koziorowski J, Mindt TL, Sollini M, Vercouillie J, Ballinger JR, Elsinga PH. EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD). Eur. J. Nuc. Med. Mol. Imaging. 2014; 41: 2175-2185
    5. Curtarello M, Zulato E, Nardo G, Valtorta S, Guzzo G, Rossi E, Esposito G, Msaki A, Pastò A, Rasola A, Persano L, Ciccarese F, Bertorelle R, Todde S, Plebani M, Schroer H, Walenta S, Mueller-Klieser W, Amadori A, Moresco RM, Indraccolo S. VEGF targeted therapy stably modulates the glycolytic phenotype of tumor cells. Cancer Research. 2015; January (1), 75:120-133

    last update: January 2018